Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Favipiravir tablet bulk supplier for pharma manufacturers

Favipiravir Tablet 200 mg, 400 mg, 600 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 200 mg, 400 mg, 600 mg

Reference Brands: Fabiflu, Favicovid, Covihalt, Avifavir, Avigan, Favira , Favilow(Globally, Not approved in USA & EU)

Category: Anti Covid Medicines

Favipiravir, an antiviral used for mild to moderate COVID-19, is approved in countries like India, Japan, and Russia, under brands such as Fabiflu, Avigan, and Avifavir. Though not approved in the US or EU, it's widely sourced across Asia, LATAM, and MENA. PharmaB2B platforms connect buyers with trusted Favipiravir exporters and manufacturers, offering bulk supply, global reach, and regulatory-compliant sourcing.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Favipiravir is a broad-spectrum antiviral used in the treatment of mild to moderate COVID-19 in countries like India, Japan, Russia, and Bangladesh. Commonly available in 200 mg and 400 mg tablets, it is marketed under leading brands such as Fabiflu, Avigan, and Avifavir. While not approved in the US or EU, Favipiravir remains in demand across Asia, the Middle East, and Latin America. Global PharmaB2B platforms connect verified Favipiravir suppliers, manufacturers, and exporters, ensuring regulatory-compliant sourcing, competitive pricing, and bulk availability. Partner with trusted B2B pharmaceutical networks for efficient distribution and international trade.

Favipiravir Tablet — third party manufacturing & bulk supply

Favipiravir Tablet 200 mg, 400 mg, 600 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Favipiravir Tablet is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Favipiravir Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Favipiravir Tablet →
Back to Listing

Frequently Asked Questions

Favipiravir tablet is listed as Tablet in 200 mg, 400 mg, 600 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Favipiravir tablet is referenced against Fabiflu, Favicovid, Covihalt, Avifavir, Avigan, Favira , Favilow(Globally, Not approved in USA & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Remdesivir

Strength:
Powder(100 mg/vial); Injection: 100 mg/20 mL (5 mg/mL)

Form: Lyophilized powder for IV & Injection

Reference Brands: Veklury® (EU & US)

View Details
Molnupiravir

Strength:
200 mg

Form: Oral capsule

Reference Brands: Lagevrio®(Us & EU)

View Details
Tocilizumab

Strength:
IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)

Form: IV injection, SQ Injection

Reference Brands: Actemra®(US); RoActemra®(EU)

View Details
Nirmatrelvir / Ritonavir Tablet

Strength:
Nirmatrelvir(150 mg) + Ritonavir(100 mg)

Form: Tablet

Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)

View Details
Baricitinib

Strength:
2 mg, 4 mg

Form: Tablet

Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.